{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T02:37:53Z","timestamp":1774319873650,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T00:00:00Z","timestamp":1390608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00204-014-1193-y","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T02:19:59Z","timestamp":1390529999000},"page":"937-951","source":"Crossref","is-referenced-by-count":34,"title":["Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat"],"prefix":"10.1007","volume":"88","author":[{"given":"Renata","family":"Silva","sequence":"first","affiliation":[]},{"given":"Em\u00edlia","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Carmo","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Palmeira","sequence":"additional","affiliation":[]},{"given":"Daniel Jos\u00e9","family":"Barbosa","sequence":"additional","affiliation":[]},{"given":"Mariline","family":"Gameiro","sequence":"additional","affiliation":[]},{"given":"Madalena","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Maria","family":"de Lourdes Bastos","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,1,25]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","volume":"39","author":"SV Ambudkar","year":"1999","unstructured":"Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361\u2013398","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"1193_CR2","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1208\/aapsj080101","volume":"8","author":"PV Balimane","year":"2006","unstructured":"Balimane PV, Han YH, Chong S (2006) Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J 8(1):E1\u2013E13","journal-title":"AAPS J"},{"issue":"5","key":"1193_CR3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/mp800050q","volume":"5","author":"CA Barta","year":"2008","unstructured":"Barta CA, Sachs-Barrable K, Feng F, Wasan KM (2008) Effects of monoglycerides on p-glycoprotein: modulation of the activity and expression in caco-2 cell monolayers. Mol Pharm 5(5):863\u2013875","journal-title":"Mol Pharm"},{"issue":"9","key":"1193_CR4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0014-827X(99)00069-5","volume":"54","author":"E Biganzoli","year":"1999","unstructured":"Biganzoli E, Cavenaghi LA, Rossi R, Brunati MC, Nolli ML (1999) Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics. Farmaco 54(9):594\u2013599","journal-title":"Farmaco"},{"issue":"18","key":"1193_CR5","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1016\/j.bmc.2007.06.037","volume":"15","author":"RAP Castanheiro","year":"2007","unstructured":"Castanheiro RAP, Pinto MMM, Silva AMS, Cravo SMM, Gales L, Damas AM, Nazareth N, Nascimento MSJ, Eaton G (2007) Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7. Bioorganic Med Chem 15(18):6080\u20136088","journal-title":"Bioorganic Med Chem"},{"issue":"8","key":"1193_CR6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jnci\/85.8.632","volume":"85","author":"PM Chaudhary","year":"1993","unstructured":"Chaudhary PM, Roninson IB (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 85(8):632\u2013639","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1193_CR7","first-page":"361","volume":"1","author":"K Chin","year":"1990","unstructured":"Chin K, Chauhan S, Pastan I, Gottesman M (1990) Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differ 1(8):361\u2013365","journal-title":"Cell Growth Differ"},{"issue":"9","key":"1193_CR8","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.bmc.2005.12.030","volume":"14","author":"A Coi","year":"2006","unstructured":"Coi A, Massarelli I, Murgia L, Saraceno M, Calderone V, Bianucci AM (2006) Prediction of hERG potassium channel affinity by the CODESSA approach. Bioorganic Med Chem 14(9):3153\u20133159","journal-title":"Bioorganic Med Chem"},{"issue":"7","key":"1193_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/157018010791526250","volume":"7","author":"E Costa","year":"2010","unstructured":"Costa E, Sousa E, Nazareth N, Nascimento SJ, Pinto MMM (2010) Synthesis of xanthones and benzophenones as inhibitors of tumor cell growth. Lett Drug Des Discov 7(7):487\u2013493","journal-title":"Lett Drug Des Discov"},{"issue":"1\u20132","key":"1193_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tox.2006.07.025","volume":"227","author":"RJ Dinis-Oliveira","year":"2006","unstructured":"Dinis-Oliveira RJ, Duarte JA, Remiao F, Sanchez-Navarro A, Bastos ML, Carvalho F (2006a) Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology 227(1\u20132):73\u201385","journal-title":"Toxicology"},{"issue":"8","key":"1193_CR11","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.freeradbiomed.2006.06.012","volume":"41","author":"RJ Dinis-Oliveira","year":"2006","unstructured":"Dinis-Oliveira RJ, Remiao F, Duarte JA, Ferreira R, Sanchez Navarro A, Bastos ML, Carvalho F (2006b) P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity. Free Radic Biol Med 41(8):1213\u20131224","journal-title":"Free Radic Biol Med"},{"issue":"19","key":"1193_CR12","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1021\/jm900940f","volume":"52","author":"B Dorner","year":"2009","unstructured":"Dorner B, Kuntner C, Bankstahl JP, Bankstahl M, Stanek J, Wanek T, Stundner G, Mairinger S, Loscher W, Muller M, Langer O, Erker T (2009) Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier. J Med Chem 52(19):6073\u20136082","journal-title":"J Med Chem"},{"key":"1193_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/0-306-46858-1_11","volume-title":"3D QSAR in drug design volume 3 recent advances","author":"WJ Dunn","year":"2002","unstructured":"Dunn WJ, Hopfinger AJ (2002) 3D QSAR of flexible molecules using tensor representation. In: Kubinyi H, Folkers G, Martin YC (eds) 3D QSAR in drug design volume 3 recent advances, vol 3. Kluwer Academic Publishers, NewYork, pp 167\u2013182"},{"issue":"1","key":"1193_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1432-1033.1997.t01-1-00186.x","volume":"246","author":"O Fardel","year":"1997","unstructured":"Fardel O, Lecureur V, Daval S, Corlu A, Guillouzo A (1997) Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment. Eur J Biochem 246(1):186\u2013192","journal-title":"Eur J Biochem"},{"issue":"6","key":"1193_CR15","first-page":"1010","volume":"14","author":"M Froimowitz","year":"1993","unstructured":"Froimowitz M (1993) HyperChem: a software package for computational chemistry and molecular modeling. Biotechniques 14(6):1010\u20131013","journal-title":"Biotechniques"},{"issue":"8","key":"1193_CR16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/cmdc.201100102","volume":"6","author":"E Genoux-Bastide","year":"2011","unstructured":"Genoux-Bastide E, Lorendeau D, Nicolle E, Yahiaoui S, Magnard S, Di Pietro A, Baubichon-Cortay H, Boumendjel A (2011) Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1. ChemMedChem 6(8):1478\u20131484","journal-title":"ChemMedChem"},{"issue":"4","key":"1193_CR17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-009-1221-4","volume":"66","author":"S Harmsen","year":"2009","unstructured":"Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH, Schellens JH (2009) PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemother Pharmacol 66(4):765\u2013771","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"1193_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","volume":"55","author":"M Hennessy","year":"2007","unstructured":"Hennessy M, Spiers JP (2007) A primer on the mechanics of P-glycoprotein the multidrug transporter. Pharmacol Res 55(1):1\u201315","journal-title":"Pharmacol Res"},{"issue":"5\u20136","key":"1193_CR19","first-page":"831","volume":"79","author":"XF Hu","year":"1999","unstructured":"Hu XF, Slater A, Rischin D, Kantharidis P, Parkin JD, Zalcberg J (1999) Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line. Br J Cancer 79(5\u20136):831\u2013837","journal-title":"Br J Cancer"},{"issue":"4","key":"1193_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tiv.2004.08.003","volume":"19","author":"C Huynh-Delerme","year":"2005","unstructured":"Huynh-Delerme C, Huet H, Noel L, Frigieri A, Kolf-Clauw M (2005) Increased functional expression of P-glycoprotein in Caco-2 TC7 cells exposed long-term to cadmium. Toxicol In Vitro 19(4):439\u2013447","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"1193_CR21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1248\/bpb.29.779","volume":"29","author":"M Kageyama","year":"2006","unstructured":"Kageyama M, Fukushima K, Togawa T, Fujimoto K, Taki M, Nishimura A, Ito Y, Sugioka N, Shibata N, Takada K (2006) Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers. Biol Pharm Bull 29(4):779\u2013784","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"1193_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1742-7843.2009.00428.x","volume":"105","author":"M Kanaan","year":"2009","unstructured":"Kanaan M, Daali Y, Dayer P, Desmeules J (2009) Uptake\/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein. Basic Clin Pharmacol Toxicol 105(3):199\u2013206","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"1193_CR23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1021\/ci000099t","volume":"41","author":"AR Katritzky","year":"2001","unstructured":"Katritzky AR, Perumal S, Petrukhin R, Kleinpeter E (2001) CODESSA-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities. J Chem Inf Comput Sci 41(3):569\u2013574","journal-title":"J Chem Inf Comput Sci"},{"issue":"1","key":"1193_CR24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0091270007309888","volume":"48","author":"KA Kim","year":"2008","unstructured":"Kim KA, Park PW, Liu KH, Kim KB, Lee HJ, Shin JG, Park JY (2008) Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone. J Clin Pharmacol 48(1):66\u201372","journal-title":"J Clin Pharmacol"},{"issue":"1\u20132","key":"1193_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/DMR-120001389","volume":"34","author":"RB Kim","year":"2002","unstructured":"Kim RB (2002) Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev 34(1\u20132):47\u201354","journal-title":"Drug Metab Rev"},{"key":"1193_CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/9783527616824.ch5","volume-title":"QSAR: Hansch analysis and related approaches","author":"H Kubinyi","year":"2008","unstructured":"Kubinyi H (2008) Statistical Methods. In: Mannhold R, Krogsgaard-Larsen P, Timmerman H (eds) QSAR: Hansch analysis and related approaches. Wiley-VCH Verlag GmbH, Weinheim, pp 91\u2013107"},{"issue":"1","key":"1193_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","volume":"25","author":"MA Lill","year":"2010","unstructured":"Lill MA, Danielson ML (2010) Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des 25(1):13\u201319","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"1193_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0925-4439(97)00027-6","volume":"1361","author":"T Litman","year":"1997","unstructured":"Litman T, Zeuthen T, Skovsgaard T, Stein WD (1997) Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. Biochim Biophys Acta 1361(2):169\u2013176","journal-title":"Biochim Biophys Acta"},{"issue":"27","key":"1193_CR29","doi-asserted-by":"crossref","first-page":"19965","DOI":"10.1016\/S0021-9258(20)80681-4","volume":"268","author":"TW Loo","year":"1993","unstructured":"Loo TW, Clarke DM (1993) Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. J Biol Chem 268(27):19965\u201319972","journal-title":"J Biol Chem"},{"issue":"46","key":"1193_CR30","doi-asserted-by":"crossref","first-page":"44332","DOI":"10.1074\/jbc.M208433200","volume":"277","author":"TW Loo","year":"2002","unstructured":"Loo TW, Clarke DM (2002) Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein. J Biol Chem 277(46):44332\u201344338","journal-title":"J Biol Chem"},{"issue":"3","key":"1193_CR31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejmech.2007.04.011","volume":"43","author":"WJ L\u00fc","year":"2008","unstructured":"L\u00fc WJ, Chen YL, Ma WP, Zhang XY, Luan F, Liu MC, Chen XG, Hu ZD (2008) QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network. Eur J Med Chem 43(3):569\u2013576","journal-title":"Eur J Med Chem"},{"issue":"3","key":"1193_CR32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","volume":"58","author":"C Martin","year":"2000","unstructured":"Martin C, Berridge G, Higgins CF, Mistry P, Charlton P, Callaghan R (2000) Communication between multiple drug binding sites on P-glycoprotein. Mol Pharmacol 58(3):624\u2013632","journal-title":"Mol Pharmacol"},{"issue":"7","key":"1193_CR33","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/cr100446h","volume":"112","author":"K-S Masters","year":"2012","unstructured":"Masters K-S, Br\u00e4se S (2012) Xanthones from fungi, lichens, and bacteria: the natural products and their synthesis. Chem Rev 112(7):3717\u20133776","journal-title":"Chem Rev"},{"issue":"9","key":"1193_CR34","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/bjc.1998.650","volume":"78","author":"D Nielsen","year":"1998","unstructured":"Nielsen D, Eriksen J, Maare C, Jakobsen A, Skovsgaard T (1998) P-glycoprotein expression in Ehrlich ascites tumour cells after in vitro and in vivo selection with daunorubicin. Br J Cancer 78(9):1175\u20131180","journal-title":"Br J Cancer"},{"issue":"1","key":"1193_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1747-0285.2011.01089.x","volume":"78","author":"A Palmeira","year":"2011","unstructured":"Palmeira A, Rodrigues F, Sousa E, Pinto M, Vasconcelos MH, Fernandes MX (2011) New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitors. Chem Biol Drug Des 78(1):57\u201372","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"1193_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2011.10.004","volume":"83","author":"A Palmeira","year":"2012","unstructured":"Palmeira A, Vasconcelos MH, Paiva A, Fernandes MX, Pinto M, Sousa E (2012) Dual inhibitors of P-glycoprotein and tumor cell growth: (re)discovering thioxanthones. Biochem Pharmacol 83(1):57\u201368","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"1193_CR37","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/S0968-0896(02)00379-6","volume":"10","author":"M Pedro","year":"2002","unstructured":"Pedro M, Cerqueira F, Sousa MEl, Nascimento MSJ, Pinto M (2002) Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes In Vitro. Bioorg Med Chem 10(12):3725\u20133730","journal-title":"Bioorg Med Chem"},{"issue":"21","key":"1193_CR38","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2174\/092986705774370691","volume":"12","author":"MMM Pinto","year":"2005","unstructured":"Pinto MMM, Sousa ME, Nascimento MSJ (2005) Xanthone derivatives: new insights in biological activities. Curr Med Chem 12(21):2517\u20132538","journal-title":"Curr Med Chem"},{"issue":"1","key":"1193_CR39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/07357909309020260","volume":"11","author":"AR Safa","year":"1993","unstructured":"Safa AR (1993) Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells. Cancer Invest 11(1):46\u201356","journal-title":"Cancer Invest"},{"key":"1193_CR40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0076-6879(98)92023-7","volume":"292","author":"AR Safa","year":"1998","unstructured":"Safa AR (1998) Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein. Methods Enzymol 292:289\u2013307","journal-title":"Methods Enzymol"},{"issue":"1","key":"1193_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011043482142","volume":"4","author":"AR Safa","year":"2004","unstructured":"Safa AR (2004) Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators. Curr Med Chem Anticancer Agents 4(1):1\u201317","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"1\u20132","key":"1193_CR42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1432-1327.1998.2510252.x","volume":"251","author":"A Seelig","year":"1998","unstructured":"Seelig A (1998) A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 251(1\u20132):252\u2013261","journal-title":"Eur J Biochem"},{"issue":"5","key":"1193_CR43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des 24(5):417\u2013422","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"1193_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","volume":"250","author":"AB Shapiro","year":"1997","unstructured":"Shapiro AB, Ling V (1997) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250(1):130\u2013137","journal-title":"Eur J Biochem"},{"key":"1193_CR45","first-page":"227","volume":"643","author":"AB Shapiro","year":"1998","unstructured":"Shapiro AB, Ling V (1998) The mechanism of ATP-dependent multidrug transport by P-glycoprotein. Acta Physiol Scand Suppl 643:227\u2013234","journal-title":"Acta Physiol Scand Suppl"},{"issue":"1","key":"1193_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","volume":"50","author":"FJ Sharom","year":"2011","unstructured":"Sharom FJ (2011) The P-glycoprotein multidrug transporter. Essays Biochem 50(1):161\u2013178","journal-title":"Essays Biochem"},{"issue":"4","key":"1193_CR47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","volume":"85","author":"R Silva","year":"2011","unstructured":"Silva R, Carmo H, Dinis-Oliveira R, Cordeiro-da-Silva A, Lima SC, Carvalho F, de Bastos ML, Remiao F (2011) In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells. Arch Toxicol 85(4):315\u2013326","journal-title":"Arch Toxicol"},{"issue":"1","key":"1193_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2012.11.028","volume":"217","author":"R Silva","year":"2013","unstructured":"Silva R, Carmo H, Vilas-Boas V, Pinho PG, Dinis-Oliveira RJ, Carvalho F, Silva I, Correia-de-Sa P, Bastos MD, Remiao F (2013) Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells. Toxicol Lett 217(1):34\u201341","journal-title":"Toxicol Lett"},{"issue":"5","key":"1193_CR49","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s00044-012-0203-y","volume":"22","author":"E Sousa","year":"2013","unstructured":"Sousa E, Palmeira A, Cordeiro A, Sarmento B, Ferreira D, Lima R, Helena Vasconcelos M, Pinto M (2013) Bioactive xanthones with effect on P-glycoprotein and prediction of intestinal absorption. Med Chem Res 22(5):2115\u20132123","journal-title":"Med Chem Res"},{"issue":"11","key":"1193_CR50","first-page":"1897","volume":"4","author":"K Sterz","year":"2009","unstructured":"Sterz K, Mollmann L, Jacobs A, Baumert D, Wiese M (2009) Activators of P-glycoprotein: structure-activity relationships and investigation of their mode of action. Chem\u00a0Med\u00a0Chem 4(11):1897\u20131911","journal-title":"Chem\u00a0Med\u00a0Chem"},{"issue":"1","key":"1193_CR51","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)29314-9","volume":"299","author":"J Taipalensuu","year":"2001","unstructured":"Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P (2001) Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 299(1):164\u2013170","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1193_CR52","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/01480540903130658","volume":"32","author":"K Takara","year":"2009","unstructured":"Takara K, Hayashi R, Kokufu M, Yamamoto K, Kitada N, Ohnishi N, Yokoyama T (2009) Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein\/MDR1 in Caco-2 cells. Drug Chem Toxicol 32(4):332\u2013337","journal-title":"Drug Chem Toxicol"},{"issue":"12","key":"1193_CR53","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0960-894X(00)00234-1","volume":"10","author":"DN Tchamo","year":"2000","unstructured":"Tchamo DN, Dijoux-Franca MG, Mariotte AM, Tsamo E, Daskiewicz JB, Bayet C, Barron D, Conseil G, Di Pietro A (2000) Prenylated xanthones as potential P-glycoprotein modulators. Bioorg Med Chem Lett 10(12):1343\u20131345","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"1193_CR54","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/dmd.104.002485","volume":"33","author":"R Tian","year":"2005","unstructured":"Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y (2005) Functional induction and de-induction of P-glycoprotein by St. John\u2019s wort and its ingredients in a human colon adenocarcinoma cell line. Drug Metab Dispos 33(4):547\u2013554","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1193_CR55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott O, Olson AJ (2009) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"3","key":"1193_CR56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/scbi.1997.0066","volume":"8","author":"K Ueda","year":"1997","unstructured":"Ueda K, Taguchi Y, Morishima M (1997) How does P-glycoprotein recognize its substrates? Semin Cancer Biol 8(3):151\u2013159","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"1193_CR57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1043-6618(03)00158-0","volume":"48","author":"MV Varma","year":"2003","unstructured":"Varma MV, Ashokraj Y, Dey CS, Panchagnula R (2003) P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 48(4):347\u2013359","journal-title":"Pharmacol Res"},{"issue":"11","key":"1193_CR58","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/cyto.a.21135","volume":"79","author":"V Vilas-Boas","year":"2011","unstructured":"Vilas-Boas V, Silva R, Gaio AR, Martins AM, Lima SC, Cordeiro-da-Silva A, de Bastos ML, Remiao F (2011) P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging. Cytometry A 79(11):912\u2013919","journal-title":"Cytometry A"},{"key":"1193_CR59","doi-asserted-by":"crossref","unstructured":"Vilas-Boas V, Silva R, Guedes-de-Pinho P, Carvalho F, Bastos ML, Remi\u00e3o F (2013a) RBE4 cells are highly resistant to paraquat-induced cytotoxicity: studies on uptake and efflux mechanisms. J App Toxicol, Epub ahead of print","DOI":"10.1002\/jat.2926"},{"issue":"3","key":"1193_CR60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.toxlet.2013.05.005","volume":"220","author":"V Vilas-Boas","year":"2013","unstructured":"Vilas-Boas V, Silva R, Nunes C, Reis S, Ferreira L, Vieira C, Carvalho F, Bastos Mde L, Remiao F (2013b) Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin. Toxicol Lett 220(3):259\u2013266","journal-title":"Toxicol Lett"},{"issue":"8","key":"1193_CR61","doi-asserted-by":"crossref","first-page":"e74425","DOI":"10.1371\/journal.pone.0074425","volume":"8","author":"V Vilas-Boas","year":"2013","unstructured":"Vilas-Boas V, Silva R, Palmeira A, Sousa E, Ferreira LM, Branco PS, Carvalho F, MdL Bastos, Remi\u00e3o F (2013c) Development of novel rifampicin-derived P-glycoprotein activators\/inducers. Synthesis, in silico analysis and application in the RBE4 Cell model, using paraquat as substrate. PLoS ONE 8(8):e74425","journal-title":"PLoS ONE"},{"key":"1193_CR62","first-page":"177","volume-title":"Challenges and advances in computational chemistry and physics","author":"B Walczac","year":"2010","unstructured":"Walczac B, Daszykowski M, Stanimirova I (2010) Recent advances in QSAR studies: methods and applications. In: Puzyn T, Leszczy\u0144ski J, Cronin MTD (eds) Challenges and advances in computational chemistry and physics, vol 8. Springer, New York, pp 177\u2013205"},{"issue":"3","key":"1193_CR63","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/mol.106.029926","volume":"71","author":"Y Wang","year":"2007","unstructured":"Wang Y, Loo TW, Bartlett MC, Clarke DM (2007) Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones. Mol Pharmacol 71(3):751\u2013758","journal-title":"Mol Pharmacol"},{"issue":"8","key":"1193_CR64","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11095-005-5270-z","volume":"22","author":"T Watanabe","year":"2005","unstructured":"Watanabe T, Onuki R, Yamashita S, Taira K, Sugiyama Y (2005) Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells. Pharm Res 22(8):1287\u20131293","journal-title":"Pharm Res"},{"issue":"3","key":"1193_CR65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","volume":"10","author":"S Yamashita","year":"2000","unstructured":"Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10(3):195\u2013204","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"1193_CR66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/imanum\/drl016","volume":"26","author":"L Zhang","year":"2006","unstructured":"Zhang L, Zhou W, Li D-H (2006) A descent modified Polak-Ribi\u00e8re-Polyak conjugate gradient method and its global convergence. IMA J Numerl Anal 26(4):629\u2013640","journal-title":"IMA J Numerl Anal"},{"issue":"7\u20138","key":"1193_CR67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","volume":"38","author":"SF Zhou","year":"2008","unstructured":"Zhou SF (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38(7\u20138):802\u2013832","journal-title":"Xenobiotica"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-014-1193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-014-1193-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-014-1193-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T17:01:20Z","timestamp":1746118880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-014-1193-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,25]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1007\/s00204-014-1193-y","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,25]]}}}